May 08, 2020: "The U.S. Food and Drug Administration approved Retevmo (selpercatinib) capsules to treat three types of tumors – non-small cell lung...
May 8, 2020: "Pluristem Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s IND application for a Phase...
May 6, 2020: "PharmaCyte Biotech announced that it has received Medical Devices Establishment Registration with the FDA’s Center for Devices and Radiological Health (CDRH)....
May 08, 2020: "RedHill Biopharma Ltd. announced that the U.S.FDA has approved its IND application for a Phase 2a clinical study evaluating its investigational drug,...
May 06, 2020: "Amgen announced positive top-line results from the ADVANCE trial, a Phase 3, multicenter, randomized, placebo-controlled, double-blind study to assess the efficacy of...
May 8, 2020: "Amgen and Cytokinetics, Incorporated announced that the U.S.FDA has granted Fast Track designation for omecamtiv mecarbil, a novel selective cardiac myosin activator, also known as...
May 7, 2020: "Gilead Sciences, Inc. announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted regulatory approval of Veklury® (remdesivir) as a treatment...
May 07, 2020: "A new microbiome-based treatment for Clostridioides difficile infection showed success in reducing recurrence of the infection at 8 weeks, according to preliminary results released...
May 05, 2020: "Volunteers at Imperial College London are making more than 50,000 disposable visors for Imperial College Healthcare NHS Trust hospitals.
In partnership with...
May 07, 2020: "Roche announced that new data from clinical trials of 19 approved and investigational medicines across 21 cancer types, will be presented...